These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34528718)

  • 1. Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.
    Pacheco C; Wei J; Shufelt C; C Hitzeman T; Cook-Wiens G; Pepine CJ; Handberg E; Anderson RD; Petersen J; Hong T; M Shaw R; Bairey Merz CN
    Clin Cardiol; 2021 Nov; 44(11):1586-1593. PubMed ID: 34528718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
    Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
    JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac T-Tubule cBIN1-Microdomain, a Diagnostic Marker and Therapeutic Target of Heart Failure.
    Li J; Richmond B; Hong T
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
    Tamarappoo B; Samuel TJ; Elboudwarej O; Thomson LEJ; Aldiwani H; Wei J; Mehta P; Cheng S; Sharif B; AlBadri A; Handberg EM; Petersen J; Pepine CJ; Nelson MD; Bairey Merz CN
    Int J Cardiol; 2021 Mar; 327():25-30. PubMed ID: 33202262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.
    Chandramouli C; Ting TW; Tromp J; Agarwal A; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Lagerström Fermer M; Gan LM; Lund L; Shah SJ; Lam CSP
    Eur J Heart Fail; 2022 Apr; 24(4):681-684. PubMed ID: 35060248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced myocardial perfusion is common among subjects with ischemia and no obstructive coronary artery disease and heart failure with preserved ejection fraction: a report from the WISE-CVD continuation study.
    Aldiwani H; Nelson MD; Sharif B; Wei J; Samuel TJ; Suppogu N; Quesada O; Cook-Wiens G; Gill E; Szczepaniak LS; Thomson LEJ; Tamarappoo B; Asif A; Shufelt C; Berman D; Merz CNB
    Vessel Plus; 2022; 6():. PubMed ID: 35836794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial stiffness in women with ischemia and no obstructive coronary artery disease: Novel insight from left atrial feature tracking.
    Zamani SK; Samuel TJ; Wei J; Thomson LEJ; Tamarappoo B; Sharif B; Bairey Merz CN; Nelson MD
    Clin Cardiol; 2020 Sep; 43(9):986-992. PubMed ID: 32458454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVD.
    AlBadri A; Wei J; Quesada O; Mehta PK; Xiao Y; Ko YA; Anderson RD; Petersen J; Azarbal B; Samuels B; Henry TD; Cook-Wiens G; Handberg EM; Van Eyk J; Pepine CJ; Bairey Merz CN
    Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):3015-3021. PubMed ID: 33028098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia and no obstructive coronary arteries (INOCA): A narrative review.
    Mehta PK; Huang J; Levit RD; Malas W; Waheed N; Bairey Merz CN
    Atherosclerosis; 2022 Dec; 363():8-21. PubMed ID: 36423427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
    Samuel TJ; Wei J; Sharif B; Tamarappoo BK; Pattisapu V; Maughan J; Cipher DJ; Suppogu N; Aldiwani H; Thomson LEJ; Shufelt C; Berman DS; Li D; Bairey Merz CN; Nelson MD
    Int J Cardiol; 2021 May; 331():1-7. PubMed ID: 33545261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold Pressor Testing and Sympathetic Nervous System Contribution to Ischemia with No Obstructive Coronary Artery Disease: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Project.
    Wei J; Barsky LL; Jalnapurkar S; Zarrini P; Cook-Wiens G; AlBadri A; Nelson MD; Shufelt C; Sharif B; Berman DS; Thomson L; Handberg EM; Petersen JW; Anderson RD; Pepine CJ; Bairey Merz CN; Mehta PK
    Am Heart J Plus; 2022 Jan; 13():. PubMed ID: 36262746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Sinha A; Rahman H; Webb A; Shah AM; Perera D
    Eur Heart J; 2021 Nov; 42(43):4431-4441. PubMed ID: 34529791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cBIN1 Score (CS) Identifies Ambulatory HFrEF Patients and Predicts Cardiovascular Events.
    Hitzeman TC; Xie Y; Zadikany RH; Nikolova AP; Baum R; Caldaruse AM; Agvanian S; Melmed GY; McGovern DPB; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
    Front Physiol; 2020; 11():503. PubMed ID: 32670075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction.
    Ahmad A; Corban MT; Toya T; Verbrugge FH; Sara JD; Lerman LO; Borlaug BA; Lerman A
    Eur J Heart Fail; 2021 May; 23(5):765-772. PubMed ID: 32949186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Microvascular Dysfunction.
    Vancheri F; Longo G; Vancheri S; Henein M
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Microcirculation in Heart Failure with Preserved Systolic Function.
    Vasiljevic Z; Krljanac G; Zdravkovic M; Lasica R; Trifunovic D; Asanin M
    Curr Pharm Des; 2018; 24(25):2960-2966. PubMed ID: 29992878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study.
    Hage C; Svedlund S; Saraste A; Faxén UL; Benson L; Fermer ML; Gan LM; Shah SJ; Lam CSP; Lund LH
    J Card Fail; 2020 Nov; 26(11):1016-1021. PubMed ID: 32846205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    Jones E; Wei J; Nelson MD; Bakir M; Mehta PK; Shufelt C; Minissian M; Sharif B; Pepine CJ; Handberg E; Cook-Wiens G; Sopko G; Bairey Merz CN
    PLoS One; 2020; 15(12):e0243213. PubMed ID: 33270715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
    Frisk M; Le C; Shen X; Røe ÅT; Hou Y; Manfra O; Silva GJJ; van Hout I; Norden ES; Aronsen JM; Laasmaa M; Espe EKS; Zouein FA; Lambert RR; Dahl CP; Sjaastad I; Lunde IG; Coffey S; Cataliotti A; Gullestad L; Tønnessen T; Jones PP; Altara R; Louch WE
    J Am Coll Cardiol; 2021 Feb; 77(4):405-419. PubMed ID: 33509397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.